-
MannKind Corporation Reports EPS of $(0.34) vs. $(0.29) Estimate
Monday, May 9, 2011 - 4:01pm | 17MannKind Corporation (Nasdaq: MNKD) Reports EPS of $(0.34) vs. $(0.29) Estimate
-
Options Brief: Onyx Pharmaceuticals (ONXX)
Monday, May 9, 2011 - 3:31pm | 85Shares of Onyx Pharmaceuticals (NASDAQ: ONXX) are higher on the session by 2.86%, trading at $40.95. Overall call volume is now running at 2.23x the daily average, with 63% of all calls traded being purchases on the offer. 1,644 contracts have traded on the session so far. Onyx Pharmaceuticals,...
-
Agenus Upgraded by Rodman & Renshaw (AGEN)
Monday, May 9, 2011 - 2:15pm | 17Rodman & Renshaw upgrades Agenus (NASDAQ: AGEN) to Market Outperform.
-
Market update- DTG, HTZ, NUAN, AAPL, ONTY, ROSE, SYY, HRB, PETS, TSN, ZRAN, BX, KWK, TRMB, WFC
Monday, May 9, 2011 - 1:51pm | 1137Dollar Thrifty Automotive Group Inc. (NYSE:DTG) is trading at a price of $78.66 its shares added almost 13% after Hertz Global Holdings (NYSE:HTZ) raised its offer to buy the rival car-rental company. Hertz Global Holdings is trading at a price of $16.52. Currently, the company has a Market...
-
UPDATE: Hapoalim Raising Price Target On Alkermes (ALKS)
Monday, May 9, 2011 - 12:38pm | 308Hapoalim Securities is maintaining its Buy rating and raising its price target on shares of Alkermes (NASDAQ: ALKS) to $20 from $17 after the company did a deal with Elan (NYSE: ELN). In a note to clients, Hapoalim writes, "Alkermes and Elan Corporation announced that Alkermes will merge with Elan...
-
Geron Statement Regarding European Cancer Vaccine Patents
Monday, May 9, 2011 - 12:31pm | 158Geron Corporation (Nasdaq: GERN) today commented on a ruling from the European Patent Office with regard to its European patent 084139, and the issuance of a second Geron patent covering telomerase peptides, EP1783139. In a March 31 ruling, the EPO Technical Board of Appeal upheld a 2006...
-
Top Percentage Gainers and Losers as of 12pm 5/09/11 (SCEI, FFHL ROSE, SMI, DTG, HTZ, SYY, CERS, LFT, ZRAN, OXGN, MOBI, GKK, EBS, TSN)
Monday, May 9, 2011 - 12:06pm | 504Best 1) Sino Clean Energy (NASDAQ: SCEI): Trading up 26.2% from Friday's close to $2.64. Sino Clean announced a $20 million share repurchase program to take place over the next twelve months. 2) Fuwei Films (NASDAQ: FFHL): Trading up 23% from Friday's close to $3.42. Shares of Fuwei have broken...
-
Valeant CEO Says Not Ruling Out Future Hostile Bids and $500M Remaining in Buyback Program (VRX, CEPH)
Monday, May 9, 2011 - 11:34am | 50Valeant (NYSE: VRX) CEO says, "disappointed in Cephalon (NASDAQ: CEPH) outcome.... in `active discussions' with potential targets... no urgency to pursue any acquisition... not ruling out future hostile bids... $500M remaining in buyback program."
-
Benzinga's Volume Movers (ALKS, NUAN, BSFT, ROSE)
Monday, May 9, 2011 - 10:26am | 190Alkermes Inc (NASDAQ: ALKS) shares moved up 4.94% to $15.19 at 10:25 am. The volume of ALKS shares traded was 388% higher than normal. Alkermes Inc (NASDAQ: ALKS) announced its plans to merge with Elan Drug Technologies, the drug formation and manufacturing unit of Elan Corp. PLC (NYSE: ELN) in a...
-
Morning Market Losers (MBTF, OXGN, EONC, ZRAN)
Monday, May 9, 2011 - 10:04am | 104MBT Financial Corp (NASDAQ: MBTF) shares moved down 15.98% to $1.42 at 10:00 am. MBTF's trailing-twelve-month profit margin is -52.21%. OXiGENE Inc (NASDAQ: OXGN) shares dropped 15.75% to $3.00. OXGN is scheduled to report its Q1 results on May 12. eOn Communications Corporation (NASDAQ: EONC)...
-
Market Update- SRE, ISAT, THC, SYY, ONTY, TRMB, NVDA- Analysts Upgraded
Monday, May 9, 2011 - 9:57am | 1519Sempra Energy (NYSE:SRE) first-quarter profit rose to $258 million, or $1.07 a share, from $106 million. () is trading at a price of $1.69,a dramatic change of 0.06 with % change of 3.68 from its previous day's close. Currently, the company has a Market capitalization (total value of a company in...
-
Goldman Sachs Suggests Buying Calls on Vertex Pharmaceuticals (VRTX)
Monday, May 9, 2011 - 9:25am | 192Goldman Sachs is out with a research note this morning, where it suggests traders buy calls on Vertex Pharmaceuticals (NASDAQ: VRTX) ahead of several catalysts. Goldman Sachs SMid Cap Biotechnology Analyst, Terence Flynn, expects three upcoming catalysts to be positive for Buy-rated VRTX. 1....
-
UPDATE: Piper Jaffray Upgrades Infinity Pharmaceuticals to Overweight (INFI)
Monday, May 9, 2011 - 9:13am | 151Piper Jaffray is out with its report today on Infinity Pharmaceuticals (NASDAQ: INFI), upgrading INFI from Neutral to Overweight. In a note to clients, Piper Jaffray writes, "We look for shares of INFI to trade higher into ASCO next month, where Infinity will report Phase Ib proof-of-concept...
-
CEL-SCI Corporation Announces New Jersey Medical School and Veteran Affairs Medical Center is Ready to Commence Enrollment for Phase III Clinical Trial of Multikine in Head and Neck Cancer
Monday, May 9, 2011 - 9:08am | 71CEL-SCI Corporation (NYSE: CVM) announced today that, following completion of a successful site initiation visit, the New Jersey Medical School and Veterans Affairs Medical Center is ready to begin immediate enrollment of qualified patients that desire to participate in its Phase III clinical trial...
-
Jefferies Gives Update On Exact Sciences Corp; Raises PT To $9
Monday, May 9, 2011 - 9:07am | 156Yesterday at the 2011 Digestive Disease Week extravaganza in Chicago, Exact Sciences Corp (NASDAQ: EXAS) collaborator Dr. David Ahlquist of the Mayo Clinic presented initial data from the first headto-head pilot study comparing EXAS' Cologuard stool-based DNA (sDNA) test with ARUP Labs' blood-based...